| 1161 |
[Bivalirudin: Is It Standard of Care in the Cath Lab?] No, Heparin with Provisional GPI Is Still a Viable Option. |
Roxana Mehran |
May. 15. 12 |
| 1160 |
[Bivalirudin: Is It Standard of Care in the Cath Lab?] Yes, It Should Be Indicated for All Patients with STEMI. |
Adnan Kastrati |
May. 15. 12 |
| 1159 |
PCI in LM Disease: Do the Guidelines in United States Reflect the Current State of Knowledge? |
Issam D. Moussa |
May. 15. 12 |
| 1158 |
Always Single Stent in Any IVUS Findings |
Bernard R. Chevalier |
May. 15. 12 |
| 1157 |
Clinical Decision Making in Patients with Left Main Disease |
Alan C. Yeung |
May. 15. 12 |
| 1156 |
How Are Left Main and Non Left Main Bifurcations Unique: Insights from Imaging |
Akiko Maehara |
May. 15. 12 |
| 1155 |
FFR Utilization in LM PCI |
Jung-Min Ahn |
May. 15. 12 |
| 1154 |
Combination of Angiographic and Clinical Risk Scores in LM Revascularization |
Corrado Tamburino |
May. 15. 12 |
| 1153 |
Pathological Features of Peripheral Atherosclerosis: Implications for Device Development |
Gaku Nakazawa |
May. 15. 12 |
| 1152 |
Assessment of Myocardial Viability |
James K. Min |
May. 15. 12 |
